Answers are grounded in this paper and cite their sources.
The use of ergotamine tartrate for the treatment of migraine headaches was first reported in 1926 by Maier.¹Since then, a number of articles have appeared recording the results of treatment in single or in small groups of patients. The only large group is that of Tzanck,²who treated 101 patients with favorable results in a large but unstated percentage. A year ago, one of us (W. G. L.³) reviewed the literature and reported the results of parenteral injection in forty-five patients. Additional reports of treatment have appeared as follows: seven patients helped by oral administration (Podolsky⁴), headaches aborted by subcutaneous injection in fourteen of eighteen patients (Brock, O'Sullivan and Young⁵), and in each of nine patients (Logan and Allen⁶). Though the cases reported (including this series) number only 300, the dozen authors who have written on the subject are unanimous that the administration
No takes yet. Share an insight, caveat, or question.
William G. Lennox (1935) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: